Competence Centre TEDD
Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement).
Research and development are key drivers of innovation and quality in transfusion medicine. The ZHBSD promotes new diagnostic, therapeutic, and product-specific approaches – practical, patient-oriented, and in collaboration with partners from academia and the medical field. https://www.blutspendezurich.ch/r-d/innovation
TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.
This might also interest you
Partnership
Who are our Partners? What are the benefits of joining our network? How to become a Partner of CC TEDD?
About
Partnership
Team
Learn more about vision, goals, competencies and history of CC TEDD.
Who are our Partners? What are the benefits of joining our network? How to become a Partner of CC TEDD?
Meet the team and board of the Competence Centre.